Search Results 361-370 of 17304 for Cyclophosphamide
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...
Patients who have received cyclophosphamide in the last 6 months. Patients who have received ACTH and/or mycophenolate mofetil in the last 30 days. Patient ...
Chemotherapy drugs such as cyclophosphamide, topotecan, cisplatin, etoposide, vincristine, dexrazoxane, doxorubicin, temozolomide, irinotecan and ...
... cyclophosphamide, and ALLO-647. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with ...
Exposure to rituximab or cyclophosphamide on the previous 2 months. Severe interstitial lung disease defined by the presence of severe hypoxemia at rest (SO ...
It is also used to treat vernal keratoconjunctivitis (allergic eye condition) and signs and symptoms of dry eye disease. This medicine belongs to a class of ...
This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.